{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T17:11:12Z","timestamp":1779124272555,"version":"3.51.4"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"22","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM133850"],"award-info":[{"award-number":["R01GM133850"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"HHS | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM156316"],"award-info":[{"award-number":["R35GM156316"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"HHS | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS132083"],"award-info":[{"award-number":["R01NS132083"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"HHS | NIH | National Human Genome Research Institute","doi-asserted-by":"publisher","award":["RM1HG008935"],"award-info":[{"award-number":["RM1HG008935"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    N6-methyladenosine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) homeostasis is essential for development, and its dysregulation is linked to cancers and neurological disorders. However, the mechanisms regulating m\n                    <jats:sup>6<\/jats:sup>\n                    A remain unclear. Here, we identify the survival of motoneuron (SMN) protein as a novel interaction partner of METTL14, a key component of the m\n                    <jats:sup>6<\/jats:sup>\n                    A methyltransferase complex. SMN binds METTL14 via its Tudor domain in an arginine methylation-dependent manner. Mutations in the SMN Tudor domain identified in spinal muscular atrophy (SMA) disrupt its interaction with METTL14 and reduce m\n                    <jats:sup>6<\/jats:sup>\n                    A levels in patient-derived fibroblasts, linking m\n                    <jats:sup>6<\/jats:sup>\n                    A dysregulation to SMA pathology. Both SMN knockdown and SMA mutations impair m\n                    <jats:sup>6<\/jats:sup>\n                    A deposition on the mRNAs of DNA repair genes, mirroring the effects of METTL14 hypomethylation. Consequently, SMA patient fibroblasts are hypersensitive to DNA-damaging agents due to reduced levels of DNA repair gene expression. To explore the function of METTL14 arginine methylation in vivo, we generated a\n                    <jats:italic>Mettl14<\/jats:italic>\n                    methylation-deficient mouse model (\n                    <jats:italic>Mettl14<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>RK<\/jats:italic>\n                    <\/jats:sup>\n                    ). Although this model does not show SMA-like phenotypes, the mutants are partially embryonic lethal and show abnormal hematopoiesis, underscoring a role for methylated METTL14 in early development.\n                  <\/jats:p>","DOI":"10.1038\/s44319-025-00590-7","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:55:50Z","timestamp":1759751750000},"page":"5483-5500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Arginine methylation-dependent METTL14-SMN interaction regulates RNA m6A homeostasis"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3419-2461","authenticated-orcid":false,"given":"Yi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3588-7214","authenticated-orcid":false,"given":"Lili","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangbo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-5008","authenticated-orcid":false,"given":"Hoang Quoc Hai","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqun","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-1266","authenticated-orcid":false,"given":"Jiamin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-407X","authenticated-orcid":false,"given":"Binghui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4319-7424","authenticated-orcid":false,"given":"Chuan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1937-4526","authenticated-orcid":false,"given":"Yanzhong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"590_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2008.12.013","volume":"33","author":"MT Bedford","year":"2009","unstructured":"Bedford MT, Clarke SG (2009) Protein arginine methylation in mammals: who, what, and why. Mol Cell 33:1\u201313","journal-title":"Mol Cell"},{"key":"590_CR2","doi-asserted-by":"publisher","first-page":"e202201429","DOI":"10.26508\/lsa.202201429","volume":"6","author":"O Binda","year":"2023","unstructured":"Binda O, Juillard F, Ducassou JN, Kleijwegt C, Paris G, Didillon A, Baklouti F, Corpet A, Coute Y, Cote J et al (2023) SMA-linked SMN mutants prevent phase separation properties and SMN interactions with FMRP family members. Life Sci Alliance 6:e202201429","journal-title":"Life Sci Alliance"},{"key":"590_CR3","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1101\/gad.1279805","volume":"19","author":"FM Boisvert","year":"2005","unstructured":"Boisvert FM, Dery U, Masson JY, Richard S (2005a) Arginine methylation of MRE11 by PRMT1 is required for DNA damage checkpoint control. Genes Dev 19:671\u2013676","journal-title":"Genes Dev"},{"key":"590_CR4","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.4161\/cc.4.12.2250","volume":"4","author":"FM Boisvert","year":"2005","unstructured":"Boisvert FM, Rhie A, Richard S, Doherty AJ (2005b) The GAR motif of 53BP1 is arginine methylated by PRMT1 and is necessary for 53BP1 DNA binding activity. Cell Cycle 4:1834\u20131841","journal-title":"Cell Cycle"},{"key":"590_CR5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41576-022-00534-0","volume":"24","author":"K Boulias","year":"2023","unstructured":"Boulias K, Greer EL (2023) Biological roles of adenine methylation in RNA. Nat Rev Genet 24:143\u2013160","journal-title":"Nat Rev Genet"},{"key":"590_CR6","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1017\/S135583820101442X","volume":"7","author":"H Brahms","year":"2001","unstructured":"Brahms H, Meheus L, de Brabandere V, Fischer U, Luhrmann R (2001) Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B\/B\u2019 and the Sm-like protein LSm4, and their interaction with the SMN protein. RNA 7:1531\u20131542","journal-title":"RNA"},{"key":"590_CR7","doi-asserted-by":"publisher","first-page":"9780","DOI":"10.3390\/ijms23179780","volume":"23","author":"C Brobbey","year":"2022","unstructured":"Brobbey C, Liu L, Yin S, Gan W (2022) The role of protein arginine methyltransferases in DNA damage response. Int J Mol Sci 23:9780","journal-title":"Int J Mol Sci"},{"key":"590_CR8","first-page":"97","volume":"11","author":"A Brown","year":"2019","unstructured":"Brown A, Kumar S, Tchounwou PB (2019) Cisplatin-based chemotherapy of human cancers. J Cancer Sci Ther 11:97","journal-title":"J Cancer Sci Ther"},{"key":"590_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/nchembio.1810","volume":"11","author":"E Chan-Penebre","year":"2015","unstructured":"Chan-Penebre E, Kuplast KG, Majer CR, Boriack-Sjodin PA, Wigle TJ, Johnston LD, Rioux N, Munchhof MJ, Jin L, Jacques SL et al (2015) A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models. Nat Chem Biol 11:432\u2013437","journal-title":"Nat Chem Biol"},{"key":"590_CR10","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrm3185","volume":"12","author":"C Chen","year":"2011","unstructured":"Chen C, Nott TJ, Jin J, Pawson T (2011) Deciphering arginine methylation: Tudor tells the tale. Nat Rev Mol Cell Biol 12:629\u2013642","journal-title":"Nat Rev Mol Cell Biol"},{"key":"590_CR11","doi-asserted-by":"publisher","first-page":"28476","DOI":"10.1074\/jbc.M414328200","volume":"280","author":"J Cote","year":"2005","unstructured":"Cote J, Richard S (2005) Tudor domains bind symmetrical dimethylated arginines. J Biol Chem 280:28476\u201328483","journal-title":"J Biol Chem"},{"key":"590_CR12","doi-asserted-by":"publisher","first-page":"3612","DOI":"10.1016\/j.cell.2021.05.008","volume":"184","author":"EM Courchaine","year":"2021","unstructured":"Courchaine EM, Barentine AES, Straube K, Lee DR, Bewersdorf J, Neugebauer KM (2021) DMA-tudor interaction modules control the specificity of in vivo condensates. Cell 184:3612\u20133625.e3617","journal-title":"Cell"},{"key":"590_CR13","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/nbdi.1996.0010","volume":"3","author":"TO Crawford","year":"1996","unstructured":"Crawford TO, Pardo CA (1996) The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 3:97\u2013110","journal-title":"Neurobiol Dis"},{"key":"590_CR14","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1212\/01.WNL.0000132634.48815.13","volume":"63","author":"I Cusco","year":"2004","unstructured":"Cusco I, Barcelo MJ, del, Rio E, Baiget M, Tizzano EF (2004) Detection of novel mutations in the SMN Tudor domain in type I SMA patients. Neurology 63:146\u2013149","journal-title":"Neurology"},{"key":"590_CR15","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000530","volume":"6","author":"I Cusco","year":"2020","unstructured":"Cusco I, Bernal S, Blasco-Perez L, Calucho M, Alias L, Fuentes-Prior P, Tizzano EF (2020) Practical guidelines to manage discordant situations of SMN2 copy number in patients with spinal muscular atrophy. Neurol Genet 6:e530","journal-title":"Neurol Genet"},{"key":"590_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/srep01311","volume":"3","author":"S Dhar","year":"2013","unstructured":"Dhar S, Vemulapalli V, Patananan AN, Huang GL, Di Lorenzo A, Richard S, Comb MJ, Guo A, Clarke SG, Bedford MT (2013) Loss of the major Type I arginine methyltransferase PRMT1 causes substrate scavenging by other PRMTs. Sci Rep 3:1311","journal-title":"Sci Rep"},{"key":"590_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250274","volume":"54","author":"DJ DiSabato","year":"2024","unstructured":"DiSabato DJ, Marion CM, Mifflin KA, Alfredo AN, Rodgers KA, Kigerl KA, Popovich PG, McTigue DM (2024) System failure: systemic inflammation following spinal cord injury. Eur J Immunol 54:e2250274","journal-title":"Eur J Immunol"},{"key":"590_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1021\/acschembio.5b00839","volume":"11","author":"MS Eram","year":"2016","unstructured":"Eram MS, Shen Y, Szewczyk M, Wu H, Senisterra G, Li F, Butler KV, Kaniskan HU, Speed BA, Dela Sena C et al (2016) A potent, selective, and cell-active inhibitor of human type I protein arginine methyltransferases. ACS Chem Biol 11:772\u2013781","journal-title":"ACS Chem Biol"},{"key":"590_CR19","doi-asserted-by":"crossref","unstructured":"Espejo A, Bedford MT (2015) Methylarginine recognition by Tudor domains. In: Zhou M-M (ed) Histone recognition. Springer, Switzerland, pp 125\u2013147","DOI":"10.1007\/978-3-319-18102-8_6"},{"key":"590_CR20","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1039\/D3CC04654K","volume":"60","author":"WW Fan","year":"2024","unstructured":"Fan WW, Xu T, Gao J, Zhang HY, Li Y, Hu DD, Gao S, Zhang JH, Liu X, Liu D et al (2024) A bivalent inhibitor against TDRD3 to suppress phase separation of methylated G3BP1. Chem Commun 60:762\u2013765","journal-title":"Chem Commun"},{"key":"590_CR21","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.1128\/MCB.21.24.8289-8300.2001","volume":"21","author":"WJ Friesen","year":"2001","unstructured":"Friesen WJ, Paushkin S, Wyce A, Massenet S, Pesiridis GS, Van Duyne G, Rappsilber J, Mann M, Dreyfuss G (2001) The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins. Mol Cell Biol 21:8289\u20138300","journal-title":"Mol Cell Biol"},{"key":"590_CR22","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/3030","volume":"20","author":"DK Gavrilov","year":"1998","unstructured":"Gavrilov DK, Shi X, Das K, Gilliam TC, Wang CH (1998) Differential SMN2 expression associated with SMA severity. Nat Genet 20:230\u2013231","journal-title":"Nat Genet"},{"key":"590_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24798-y","volume":"12","author":"V Giuliani","year":"2021","unstructured":"Giuliani V, Miller MA, Liu CY, Hartono SR, Class CA, Bristow CA, Suzuki E, Sanz LA, Gao G, Gay JP et al (2021) PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma. Nat Commun 12:4626","journal-title":"Nat Commun"},{"key":"590_CR24","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.1093\/hmg\/ddn203","volume":"17","author":"I Goulet","year":"2008","unstructured":"Goulet I, Boisvenue S, Mokas S, Mazroui R, Cote J (2008) TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic stress granules. Hum Mol Genet 17:3055\u20133074","journal-title":"Hum Mol Genet"},{"key":"590_CR25","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.molcel.2012.12.009","volume":"49","author":"C Grimm","year":"2013","unstructured":"Grimm C, Chari A, Pelz JP, Kuper J, Kisker C, Diederichs K, Stark H, Schindelin H, Fischer U (2013) Structural basis of assembly chaperone-mediated snRNP formation. Mol Cell 49:692\u2013703","journal-title":"Mol Cell"},{"key":"590_CR26","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41588-021-00829-8","volume":"53","author":"Z Gu","year":"2021","unstructured":"Gu Z, Liu Y, Zhang Y, Cao H, Lyu J, Wang X, Wylie A, Newkirk SJ, Jones AE, Lee M Jr et al (2021) Silencing of LINE-1 retrotransposons is a selective dependency of myeloid leukemia. Nat Genet 53:672\u2013682","journal-title":"Nat Genet"},{"key":"590_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/s41375-024-02222-w","volume":"38","author":"J Guo","year":"2024","unstructured":"Guo J, Buettner R, Du L, Li Z, Liu W, Su R, Chen Z, Che Y, Zhang Y, Ma R et al (2024) 8-Cl-Ado and 8-NH(2)-Ado synergize with venetoclax to target the methionine-MAT2A-SAM axis in acute myeloid leukemia. Leukemia 38:1236\u20131245","journal-title":"Leukemia"},{"key":"590_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep00227","volume":"2","author":"RM Hallett","year":"2012","unstructured":"Hallett RM, Dvorkin-Gheva A, Bane A, Hassell JA (2012) A gene signature for predicting outcome in patients with basal-like breast cancer. Sci Rep 2:227","journal-title":"Sci Rep"},{"key":"590_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.stem.2022.12.006","volume":"30","author":"L Han","year":"2023","unstructured":"Han L, Dong L, Leung K, Zhao Z, Li Y, Gao L, Chen Z, Xue J, Qing Y, Li W et al (2023) METTL16 drives leukemogenesis and leukemia stem cell self-renewal by reprogramming BCAA metabolism. Cell Stem Cell 30:52\u201368.e13","journal-title":"Cell Stem Cell"},{"key":"590_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1336-6","volume":"18","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Shi H, He C (2017) Epitranscriptomic influences on development and disease. Genome Biol 18:197","journal-title":"Genome Biol"},{"key":"590_CR31","doi-asserted-by":"publisher","first-page":"3061","DOI":"10.1093\/nar\/gky103","volume":"46","author":"L Huang","year":"2018","unstructured":"Huang L, Wang Z, Narayanan N, Yang Y (2018) Arginine methylation of the C-terminus RGG motif promotes TOP3B topoisomerase activity and stress granule localization. Nucleic Acids Res 46:3061\u20133074","journal-title":"Nucleic Acids Res"},{"key":"590_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0395-8","volume":"9","author":"SR Jaffrey","year":"2017","unstructured":"Jaffrey SR, Kharas MG (2017) Emerging links between m(6)A and misregulated mRNA methylation in cancer. Genome Med 9:2","journal-title":"Genome Med"},{"key":"590_CR33","doi-asserted-by":"publisher","first-page":"E2347","DOI":"10.1073\/pnas.1613181114","volume":"114","author":"M Jangi","year":"2017","unstructured":"Jangi M, Fleet C, Cullen P, Gupta SV, Mekhoubad S, Chiao E, Allaire N, Bennett CF, Rigo F, Krainer AR et al (2017) SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage. Proc Natl Acad Sci USA 114:E2347\u2013E2356","journal-title":"Proc Natl Acad Sci USA"},{"key":"590_CR34","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","volume":"17","author":"S Kariya","year":"2008","unstructured":"Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, Landmesser LT, Monani UR (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 17:2552\u20132569","journal-title":"Hum Mol Genet"},{"key":"590_CR35","doi-asserted-by":"publisher","first-page":"e202101145","DOI":"10.26508\/lsa.202101145","volume":"5","author":"E Karyka","year":"2022","unstructured":"Karyka E, Berrueta Ramirez N, Webster CP, Marchi PM, Graves EJ, Godena VK, Marrone L, Bhargava A, Ray S, Ning K et al (2022) SMN-deficient cells exhibit increased ribosomal DNA damage. Life Sci Alliance 5:e202101145","journal-title":"Life Sci Alliance"},{"key":"590_CR36","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00415-006-0410-x","volume":"254","author":"T Kotani","year":"2007","unstructured":"Kotani T, Sutomo R, Sasongko TH, Sadewa AH, Gunadi, Minato T, Fujii E, Endo S, Lee MJ, Ayaki H et al (2007) A novel mutation at the N-terminal of SMN Tudor domain inhibits its interaction with target proteins. J Neurol 254:624\u2013630","journal-title":"J Neurol"},{"key":"590_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101461","volume":"5","author":"B Ku","year":"2024","unstructured":"Ku B, Eisenbarth D, Baek S, Jeong TK, Kang JG, Hwang D, Noh MG, Choi C, Choi S, Seol T et al (2024) PRMT1 promotes pancreatic cancer development and resistance to chemotherapy. Cell Rep Med 5:101461","journal-title":"Cell Rep Med"},{"key":"590_CR38","doi-asserted-by":"publisher","first-page":"R666","DOI":"10.1016\/j.cub.2010.05.056","volume":"20","author":"P Lasko","year":"2010","unstructured":"Lasko P (2010) Tudor domain. Curr Biol: CB 20:R666\u2013R667","journal-title":"Curr Biol: CB"},{"key":"590_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M et al (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80:155\u2013165","journal-title":"Cell"},{"key":"590_CR40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI173702","volume":"134","author":"DM Leow","year":"2024","unstructured":"Leow DM, Ng YK, Wang LC, Koh HW, Zhao T, Khong ZJ, Tabaglio T, Narayanan G, Giadone RM, Sobota RM et al (2024) Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy. J Clin Invest 134:e173702","journal-title":"J Clin Invest"},{"key":"590_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23537","volume":"38","author":"Z Li","year":"2024","unstructured":"Li Z, Meng D, Liu Y, Bi F, Tian K, Xu J, Sun J, Gu C, Li Y (2024) Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation. J Biochem Mol Toxicol 38:e23537","journal-title":"J Biochem Mol Toxicol"},{"key":"590_CR42","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1002\/j.1460-2075.1996.tb00725.x","volume":"15","author":"Q Liu","year":"1996","unstructured":"Liu Q, Dreyfuss G (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J 15:3555\u20133565","journal-title":"EMBO J"},{"key":"590_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24035-6","volume":"12","author":"XN Liu","year":"2021","unstructured":"Liu XN, Wang HL, Zhao XY, Luo QZ, Wang QW, Tan KF, Wang ZH, Jiang J, Cui JR, Du EH et al (2021) Arginine methylation of METTL14 promotes RNA N-6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells. Nat Commun 12:3780","journal-title":"Nat Commun"},{"key":"590_CR44","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/ng0598-63","volume":"19","author":"CL Lorson","year":"1998","unstructured":"Lorson CL, Strasswimmer J, Yao JM, Baleja JD, Hahnen E, Wirth B, Le T, Burghes AH, Androphy EJ (1998) SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat Genet 19:63\u201366","journal-title":"Nat Genet"},{"key":"590_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3892\/ol.2020.12423","volume":"21","author":"H Matsubara","year":"2021","unstructured":"Matsubara H, Fukuda T, Awazu Y, Nanno S, Shimomura M, Inoue Y, Yamauchi M, Yasui T, Sumi T (2021) PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma. Oncol Lett 21:162","journal-title":"Oncol Lett"},{"key":"590_CR46","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1093\/emboj\/20.9.2304","volume":"20","author":"G Meister","year":"2001","unstructured":"Meister G, Hannus S, Plottner O, Baars T, Hartmann E, Fakan S, Laggerbauer B, Fischer U (2001) SMNrp is an essential pre-mRNA splicing factor required for the formation of the mature spliceosome. EMBO J 20:2304\u20132314","journal-title":"EMBO J"},{"key":"590_CR47","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-022-00380-8","volume":"8","author":"E Mercuri","year":"2022","unstructured":"Mercuri E, Sumner CJ, Muntoni F, Darras BT, Finkel RS (2022) Spinal muscular atrophy. Nat Rev Dis Prim 8:52","journal-title":"Nat Rev Dis Prim"},{"key":"590_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-70289-3","volume":"10","author":"MF Montenegro","year":"2020","unstructured":"Montenegro MF, Gonzalez-Guerrero R, Sanchez-Del-Campo L, Pinero-Madrona A, Cabezas-Herrera J, Rodriguez-Lopez JN (2020) PRMT1-dependent methylation of BRCA1 contributes to the epigenetic defense of breast cancer cells against ionizing radiation. Sci Rep 10:13275","journal-title":"Sci Rep"},{"key":"590_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04955-4","volume":"7","author":"A Morettin","year":"2017","unstructured":"Morettin A, Paris G, Bouzid Y, Baldwin RM, Falls TJ, Bell JC, Cote J (2017) Tudor domain containing protein 3 promotes tumorigenesis and invasive capacity of breast cancer cells. Sci Rep 7:5153","journal-title":"Sci Rep"},{"key":"590_CR50","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.celrep.2019.12.061","volume":"30","author":"D Musiani","year":"2020","unstructured":"Musiani D, Giambruno R, Massignani E, Ippolito MR, Maniaci M, Jammula S, Manganaro D, Cuomo A, Nicosia L, Pasini D et al (2020) PRMT1 is recruited via DNA-PK to chromatin where it sustains the senescence-associated secretory phenotype in response to cisplatin. Cell Rep 30:1208\u20131222.e1209","journal-title":"Cell Rep"},{"key":"590_CR51","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1349-7006.2004.tb02206.x","volume":"95","author":"T Nagahata","year":"2004","unstructured":"Nagahata T, Onda M, Emi M, Nagai H, Tsumagari K, Fujimoto T, Hirano A, Sato T, Nishikawa K, Akiyama F et al (2004) Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray. Cancer Sci 95:218\u2013225","journal-title":"Cancer Sci"},{"key":"590_CR52","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrc.2017.116","volume":"18","author":"G Nalepa","year":"2018","unstructured":"Nalepa G, Clapp DW (2018) Fanconi anaemia and cancer: an intricate relationship. Nat Rev Cancer 18:168\u2013185","journal-title":"Nat Rev Cancer"},{"key":"590_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2016.48","volume":"3","author":"N Narayanan","year":"2017","unstructured":"Narayanan N, Wang Z, Li L, Yang Y (2017) Arginine methylation of USP9X promotes its interaction with TDRD3 and its anti-apoptotic activities in breast cancer cells. Cell Discov 3:16048","journal-title":"Cell Discov"},{"key":"590_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114176","volume":"43","author":"CDK Nguyen","year":"2024","unstructured":"Nguyen CDK, Colon-Emeric BA, Murakami S, Shujath MNY, Yi C (2024) PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer. Cell Rep 43:114176","journal-title":"Cell Rep"},{"key":"590_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13045-018-0590-8","volume":"11","author":"Y Pan","year":"2018","unstructured":"Pan Y, Ma P, Liu Y, Li W, Shu Y (2018) Multiple functions of m(6)A RNA methylation in cancer. J Hematol Oncol 11:48","journal-title":"J Hematol Oncol"},{"key":"590_CR56","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1242\/dev.073304","volume":"139","author":"JW Pek","year":"2012","unstructured":"Pek JW, Anand A, Kai T (2012) Tudor domain proteins in development. Development 139:2255\u20132266","journal-title":"Development"},{"key":"590_CR57","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/83014","volume":"8","author":"P Selenko","year":"2001","unstructured":"Selenko P, Sprangers R, Stier G, Buhler D, Fischer U, Sattler M (2001) SMN tudor domain structure and its interaction with the Sm proteins. Nat Struct Biol 8:27\u201331","journal-title":"Nat Struct Biol"},{"key":"590_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47107-9","volume":"15","author":"L Shen","year":"2024","unstructured":"Shen L, Ma X, Wang Y, Wang Z, Zhang Y, Pham HQH, Tao X, Cui Y, Wei J, Lin D et al (2024) Loss-of-function mutation in PRMT9 causes abnormal synapse development by dysregulation of RNA alternative splicing. Nat Commun 15:2809","journal-title":"Nat Commun"},{"key":"590_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.166063","volume":"1867","author":"NN Singh","year":"2021","unstructured":"Singh NN, Hoffman S, Reddi PP, Singh RN (2021) Spinal muscular atrophy: Broad disease spectrum and sex-specific phenotypes. Biochim Biophys Acta Mol Basis Dis 1867:166063","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"590_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.bbagrm.2016.12.008","volume":"1860","author":"RN Singh","year":"2017","unstructured":"Singh RN, Howell MD, Ottesen EW, Singh NN (2017) Diverse role of survival motor neuron protein. Biochim Biophys Acta Gene Regul Mech 1860:299\u2013315","journal-title":"Biochim Biophys Acta Gene Regul Mech"},{"key":"590_CR61","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1002\/mgg3.141","volume":"3","author":"DL Stabley","year":"2015","unstructured":"Stabley DL, Harris AW, Holbrook J, Chubbs NJ, Lozo KW, Crawford TO, Swoboda KJ, Funanage VL, Wang W, Mackenzie W et al (2015) SMN1 and SMN2 copy numbers in cell lines derived from patients with spinal muscular atrophy as measured by array digital PCR. Mol Genet Genom Med 3:248\u2013257","journal-title":"Mol Genet Genom Med"},{"key":"590_CR62","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.nmd.2017.02.002","volume":"27","author":"DL Stabley","year":"2017","unstructured":"Stabley DL, Holbrook J, Harris AW, Swoboda KJ, Crawford TO, Sol-Church K, Butchbach MER (2017) Establishing a reference dataset for the authentication of spinal muscular atrophy cell lines using STR profiling and digital PCR. Neuromuscul Disord 27:439\u2013446","journal-title":"Neuromuscul Disord"},{"key":"590_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0736-y","volume":"13","author":"X Sun","year":"2016","unstructured":"Sun X, Jones ZB, Chen XM, Zhou L, So KF, Ren Y (2016) Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation 13:260","journal-title":"J Neuroinflammation"},{"key":"590_CR64","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.braindev.2017.03.002","volume":"39","author":"T Takarada","year":"2017","unstructured":"Takarada T, Ar Rochmah M, Harahap NIF, Shinohara M, Saito T, Saito K, Lai PS, Bouike Y, Takeshima Y, Awano H et al (2017) SMA mutations in SMN Tudor and C-terminal domains destabilize the protein. Brain Dev 39:606\u2013612","journal-title":"Brain Dev"},{"key":"590_CR65","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/nsmb.2185","volume":"18","author":"K Tripsianes","year":"2011","unstructured":"Tripsianes K, Madl T, Machyna M, Fessas D, Englbrecht C, Fischer U, Neugebauer KM, Sattler M (2011) Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins. Nat Struct Mol Biol 18:1414\u20131420","journal-title":"Nat Struct Mol Biol"},{"key":"590_CR66","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","volume":"23","author":"LP Vu","year":"2017","unstructured":"Vu LP, Pickering BF, Cheng Y, Zaccara S, Nguyen D, Minuesa G, Chou T, Chow A, Saletore Y, MacKay M et al (2017) The N(6)-methyladenosine (m(6)A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells. Nat Med 23:1369\u20131376","journal-title":"Nat Med"},{"key":"590_CR67","doi-asserted-by":"publisher","first-page":"3692","DOI":"10.1016\/j.molcel.2024.09.005","volume":"84","author":"GM Wadsworth","year":"2024","unstructured":"Wadsworth GM, Srinivasan S, Lai LB, Datta M, Gopalan V, Banerjee PR (2024) RNA-driven phase transitions in biomolecular condensates. Mol Cell 84:3692\u20133705","journal-title":"Mol Cell"},{"key":"590_CR68","doi-asserted-by":"publisher","first-page":"5543","DOI":"10.1128\/MCB.25.13.5543-5551.2005","volume":"25","author":"L Wan","year":"2005","unstructured":"Wan L, Battle DJ, Yong J, Gubitz AK, Kolb SJ, Wang J, Dreyfuss G (2005) The survival of motor neurons protein determines the capacity for snRNP assembly: biochemical deficiency in spinal muscular atrophy. Mol Cell Biol 25:5543\u20135551","journal-title":"Mol Cell Biol"},{"key":"590_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100912","volume":"42","author":"J Wang","year":"2023","unstructured":"Wang J, Wang Z, Inuzuka H, Wei W, Liu J (2023a) PRMT1 methylates METTL14 to modulate its oncogenic function. Neoplasia 42:100912","journal-title":"Neoplasia"},{"key":"590_CR70","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202303812","volume":"10","author":"Y Wang","year":"2023","unstructured":"Wang Y, Wang C, Guan X, Ma Y, Zhang S, Li F, Yin Y, Sun Z, Chen X, Yin H (2023b) PRMT3-mediated arginine methylation of METTL14 promotes malignant progression and treatment resistance in endometrial carcinoma. Adv Sci 10:e2303812","journal-title":"Adv Sci"},{"key":"590_CR71","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106309","volume":"40","author":"Z Wang","year":"2021","unstructured":"Wang Z, Pan Z, Adhikari S, Harada BT, Shen L, Yuan W, Abeywardana T, Al-Hadid Q, Stark JM, He C et al (2021) m(6) A deposition is regulated by PRMT1-mediated arginine methylation of METTL14 in its disordered C-terminal region. EMBO J 40:e106309","journal-title":"EMBO J"},{"key":"590_CR72","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","volume":"22","author":"H Weng","year":"2018","unstructured":"Weng H, Huang H, Wu H, Qin X, Zhao BS, Dong L, Shi H, Skibbe J, Shen C, Hu C et al (2018) METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification. Cell Stem Cell 22:191\u2013205.e199","journal-title":"Cell Stem Cell"},{"key":"590_CR73","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrc3409","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang Y, Bedford MT (2013) Protein arginine methyltransferases and cancer. Nat Rev Cancer 13:37\u201350","journal-title":"Nat Rev Cancer"},{"key":"590_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7428","volume":"6","author":"Y Yang","year":"2015","unstructured":"Yang Y, Hadjikyriacou A, Xia Z, Gayatri S, Kim D, Zurita-Lopez C, Kelly R, Guo A, Li W, Clarke SG et al (2015) PRMT9 is a type II methyltransferase that methylates the splicing factor SAP145. Nat Commun 6:6428","journal-title":"Nat Commun"},{"key":"590_CR75","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.molcel.2010.11.024","volume":"40","author":"Y Yang","year":"2010","unstructured":"Yang Y, Lu Y, Espejo A, Wu J, Xu W, Liang S, Bedford MT (2010) TDRD3 is an effector molecule for arginine-methylated histone marks. Mol Cell 40:1016\u20131023","journal-title":"Mol Cell"},{"key":"590_CR76","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.molcel.2014.01.011","volume":"53","author":"Y Yang","year":"2014","unstructured":"Yang Y, McBride KM, Hensley S, Lu Y, Chedin F, Bedford MT (2014) Arginine methylation facilitates the recruitment of TOP3B to chromatin to prevent R loop accumulation. Mol Cell 53:484\u2013497","journal-title":"Mol Cell"},{"key":"590_CR77","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41422-018-0062-2","volume":"28","author":"QJ Yao","year":"2018","unstructured":"Yao QJ, Sang L, Lin M, Yin X, Dong W, Gong Y, Zhou BO (2018) Mettl3-Mettl14 methyltransferase complex regulates the quiescence of adult hematopoietic stem cells. Cell Res 28:952\u2013954","journal-title":"Cell Res"},{"key":"590_CR78","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.pediatrneurol.2020.01.003","volume":"109","author":"CJJ Yeo","year":"2020","unstructured":"Yeo CJJ, Darras BT (2020) Overturning the paradigm of spinal muscular atrophy as just a motor neuron disease. Pediatr Neurol 109:12\u201319","journal-title":"Pediatr Neurol"},{"key":"590_CR79","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.cell.2017.09.003","volume":"171","author":"KJ Yoon","year":"2017","unstructured":"Yoon KJ, Ringeling FR, Vissers C, Jacob F, Pokrass M, Jimenez-Cyrus D, Su Y, Kim NS, Zhu Y, Zheng L et al (2017) Temporal control of mammalian cortical neurogenesis by m(6)A methylation. Cell 171:877\u2013889.e817","journal-title":"Cell"},{"key":"590_CR80","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1128\/MCB.00042-09","volume":"29","author":"Z Yu","year":"2009","unstructured":"Yu Z, Chen T, Hebert J, Li E, Richard S (2009) A mouse PRMT1 null allele defines an essential role for arginine methylation in genome maintenance and cell proliferation. Mol Cell Biol 29:2982\u20132996","journal-title":"Mol Cell Biol"},{"key":"590_CR81","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1093\/nar\/gkab642","volume":"49","author":"W Yuan","year":"2021","unstructured":"Yuan W, Al-Hadid Q, Wang Z, Shen L, Cho H, Wu X, Yang Y (2021) TDRD3 promotes DHX9 chromatin recruitment and R-loop resolution. Nucleic Acids Res 49:8573\u20138591","journal-title":"Nucleic Acids Res"},{"key":"590_CR82","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","volume":"20","author":"S Zaccara","year":"2019","unstructured":"Zaccara S, Ries RJ, Jaffrey SR (2019) Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol 20:608\u2013624","journal-title":"Nat Rev Mol Cell Biol"},{"key":"590_CR83","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature16469","volume":"529","author":"DY Zhao","year":"2016","unstructured":"Zhao DY, Gish G, Braunschweig U, Li Y, Ni Z, Schmitges FW, Zhong G, Liu K, Li W, Moffat J et al (2016) SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination. Nature 529:48\u201353","journal-title":"Nature"},{"key":"590_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107819","volume":"31","author":"Z Zheng","year":"2020","unstructured":"Zheng Z, Zhang L, Cui XL, Yu X, Hsu PJ, Lyu R, Tan H, Mandal M, Zhang M, Sun HL et al (2020) Control of early B cell development by the RNA N(6)-methyladenosine methylation. Cell Rep 31:107819","journal-title":"Cell Rep"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-025-00590-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00590-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T16:43:22Z","timestamp":1779122602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-025-00590-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":84,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11,20]]}},"alternative-id":["590"],"URL":"https:\/\/doi.org\/10.1038\/s44319-025-00590-7","relation":{},"ISSN":["1469-3178"],"issn-type":[{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CH is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio and Ellis Bio, a scientific cofounder and equity holder of Accent Therapeutics, and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}